Sue Shao joined Vivo in 2016. Before joining Vivo, Sue worked as a private equity associate focusing on healthcare sector investment at China International Capital Corporation Limited from 2013 to 2015, where she participated and executed investments in Betta Pharmaceuticals and Shanghai SynTheAll Pharmaceutical, a subsidiary of Wuxi AppTec.
Sue graduated from London School of Economics with an M.S. in International Management, and received a B.S. in Accounting and Finance from University of Manchester. Sue also completed an Exchange MBA from Chicago Booth School of Business.